LISATA THERAPEUTICS, INC. — Director's Dealing 2015

Jan 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2015-01-02

Reporting Person: KLOSK STEVEN M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-02	Common Stock, $0.001 par value	A	12000	—	Acquired	22000	Direct

Footnotes

F1: On January 2, 2015 (the "Grant Date"), the Reporting Person was granted an award of 19,000 shares of the Issuer's common stock, $.001 par value, subject to all of the terms and conditions of the Issuer's 2009 Amended & Restated Equity Compensation Plan. The grant was made pursuant to the Issuer's Director Compensation Plan. This award was fully vested on the Grant Date.